Medtronic plc is 46.9x more valuable than Axogen, Inc. by market capitalization ($103.03 B vs $2.20 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | MDT | AXGN |
|---|---|---|
| Market cap | $103.03 B | $2.20 B |
| US-listed rank | #146 | #2035 |
| Revenue (latest FY) | $33.54B | $225.21M |
| Net income (latest FY) | $4.66B | -$15.70M |
| Net margin | 13.9% | -7.0% |
| P/E (trailing FY) | 22.1 | - |
| SEC filings | 998 | 1,334 |
Medtronic plc is 46.9x more valuable than Axogen, Inc. by market capitalization ($103.03 B vs $2.20 B).
In their latest fiscal years, Medtronic plc reported $33.54B in revenue while Axogen, Inc. reported $225.21M.
Full pages: Medtronic plc and Axogen, Inc., or browse the full rankings.